Prothena Corp Public (PRTA) Operating Expenses (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Operating Expenses of $21.0 million for Q1 2026, down 69.23% year-over-year from $68.4 million in Q1 2025, and down 13.11% quarter-over-quarter from $24.2 million in Q4 2025.
Prothena Corp Public (PRTA) Operating Expenses (2012 - 2026) Analysis & Trends
Prothena Corp Public's Operating Expenses history runs 15 years deep, the most recent figure standing at $21.0 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 69.23% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $177.0 million (down 36.01% YoY), while the FY2025 annual figure was $224.3 million, down 22.57% from the prior year.
- Operating Expenses for Q1 2026 stood at $21.0 million, down from $24.2 million in the prior quarter.
- The five-year high for Operating Expenses was $89.0 million in Q2 2025, with the low at $21.0 million in Q1 2026.
- The 5-year median for Operating Expenses is $67.0 million (2024), against an average of $59.0 million.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses surged 73.14% in 2022, then plunged 69.23% in 2026.
- Prothena Corp Public's Operating Expenses stood at $50.0 million in 2022, then jumped by 57.68% to $78.8 million in 2023, then slipped by 14.98% to $67.0 million in 2024, then sank by 63.86% to $24.2 million in 2025, then slipped by 13.11% to $21.0 million in 2026.
- Business Quant data shows PRTA's Operating Expenses at $21.0 million in Q1 2026, $24.2 million in Q4 2025, and $42.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 22.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.11 Mn |
| Mar 31, 2026 | 21.05 Mn |
| Dec 31, 2025 | 24.22 Mn |
| Sep 30, 2025 | 42.66 Mn |
| Jun 30, 2025 | 89.04 Mn |
| Mar 31, 2025 | 68.41 Mn |
| Dec 31, 2024 | 67.02 Mn |
| Sep 30, 2024 | 67.48 Mn |
| Jun 30, 2024 | 73.64 Mn |
| Mar 31, 2024 | 81.58 Mn |
| Dec 31, 2023 | 78.83 Mn |
| Sep 30, 2023 | 74.56 Mn |
| Jun 30, 2023 | 70.52 Mn |
| Mar 31, 2023 | 58.49 Mn |
| Dec 31, 2022 | 50.00 Mn |
| Sep 30, 2022 | 51.85 Mn |
| Jun 30, 2022 | 44.52 Mn |
| Mar 31, 2022 | 39.10 Mn |
| Dec 31, 2021 | 34.26 Mn |
| Sep 30, 2021 | 29.95 Mn |